https://rhiviera.com/publication/breast-cancer-treatment-a-phased-approach-to-implementation/2022-04-06T17:30:02+02:00https://rhiviera.com/publication/determining-prognosis-in-acute-exacerbation-of-copd/2022-04-06T17:31:48+02:00https://rhiviera.com/publication/structural-biology-of-hiv/2022-04-06T17:25:09+02:00https://rhiviera.com/publication/future-technologies-for-monitoring-hiv-drug-resistance-and-cure/2022-04-06T17:30:58+02:00https://rhiviera.com/publication/metabolic-plasticity-of-hiv-specific-cd8-t-cells-is-associated-with-enhanced-antiviral-potential-and-natural-control-of-hiv-1-infection/2022-04-06T17:33:03+02:00https://rhiviera.com/publication/the-yellow-brick-road-towards-hiv-eradication/2022-04-06T17:34:28+02:00https://rhiviera.com/publication/cellular-metabolism-is-a-major-determinant-of-hiv-1-reservoir-seeding-in-cd4-t-cells-and-offers-an-opportunity-to-tackle-infection/2022-04-06T17:35:09+02:00https://rhiviera.com/publication/hiv-dna-a-clinical-marker-of-hiv-reservoirs/2022-04-06T17:36:48+02:00https://rhiviera.com/publication/cellular-determinants-of-hiv-persistence-on-antiretroviral-therapy/2022-04-06T17:37:54+02:00https://rhiviera.com/publication/total-hiv-dna-a-global-marker-of-hiv-persistence/2022-03-10T17:51:08+01:00https://rhiviera.com/publication/comprehensive-mass-cytometry-analysis-of-cell-cycle-activation-and-coinhibitory-receptors-expression-in-cd4-t-cells-from-healthy-and-hiv-infected-individuals/2022-04-06T17:39:00+02:00https://rhiviera.com/publication/ultrasensitive-hiv-1-p24-assay-detects-single-infected-cells-and-differences-in-reservoir-induction-by-latency-reversal-agents/2022-04-06T17:38:30+02:00https://rhiviera.com/publication/hiv-1-virological-remission-lasting-more-than-12-years-after-interruption-of-early-antiretroviral-therapy-in-a-perinatally-infected-teenager-enrolled-in-the-french-anrs-epf-co10-paediatric-cohort-a-c/2022-04-06T17:40:23+02:00https://rhiviera.com/publication/total-hiv-1-dna-a-marker-of-viral-reservoir-dynamics-with-clinical-implications/2022-04-06T17:39:39+02:00https://rhiviera.com/publication/intensive-five-drug-antiretroviral-therapy-regimen-versus-standard-triple-drug-therapy-during-primary-hiv-1-infection-optiprim-anrs-147-a-randomised-open-label-phase-3-trial/2022-04-06T17:41:22+02:00https://rhiviera.com/publication/post-treatment-hiv-1-controllers-with-a-long-term-virological-remission-after-the-interruption-of-early-initiated-antiretroviral-therapy-anrs-visconti-study/2022-04-06T17:42:26+02:00https://rhiviera.com/publication/immunometabolism-and-hiv-1-pathogenesis-food-for-thought/2022-04-06T17:28:33+02:00https://rhiviera.com/publication/extremely-low-viral-reservoir-in-treated-chronically-hiv-1-infected-individuals/2022-04-06T17:29:20+02:00https://rhiviera.com/publication/antiapoptotic-clone-11-derived-peptides-induce-in-vitro-death-of-cd4-t-cells-susceptible-to-hiv-1-infection/2022-04-06T17:28:57+02:00https://rhiviera.com/publication/siv-induced-terminally-differentiated-adaptive-nk-cells-in-lymph-nodes-associated-with-enhanced-mhc-e-restricted-activity/2022-04-06T17:27:59+02:00https://rhiviera.com/publication/role-of-nkg2a-c-cd8-t-cells-in-pathogenic-versus-non-pathogenic-siv-infections/2022-04-06T17:27:19+02:00https://rhiviera.com/publication/ultrasensitive-detection-of-p24-in-plasma-samples-from-people-with-primary-and-chronic-hiv-1-infection/2022-04-06T17:09:23+02:00https://rhiviera.com/publication/inhibition-of-hiv-1-gene-transcription-by-kap1-in-myeloid-lineage/2022-04-06T17:11:39+02:00https://rhiviera.com/publication/expansion-of-immature-neutrophils-during-siv-infection-is-associated-with-their-capacity-to-modulate-t-cell-function/2022-04-06T17:14:14+02:00https://rhiviera.com/publication/cd32cd4-t-cells-sharing-b-cell-properties-increase-with-simian-immunodeficiency-virus-replication-in-lymphoid-tissues/2022-04-06T17:27:01+02:00https://rhiviera.com/publication/reprogramming-dysfunctional-cd8-t-cells-to-promote-properties-associated-with-natural-hiv-control/2022-06-08T13:12:40+02:00https://rhiviera.com/publication/transient-viral-exposure-drives-functionally-coordinated-humoral-immune-responses-in-hiv-1-post-treatment-controllers/2022-04-14T10:20:22+02:00https://rhiviera.com/publication/novel-role-of-uhrf1-in-the-epigenetic-repression-of-the-latent-hiv-1/2022-09-16T12:08:00+02:00https://rhiviera.com/publication/long-term-antiretroviral-therapy-initiated-during-primary-hiv-1-infection-is-key-to-achieving-both-low-hiv-reservoirs-and-normal-t-cell-counts/2022-05-31T14:58:54+02:00https://rhiviera.com/publication/dynamics-in-hiv-dna-levels-over-time-in-hiv-controllers/2022-05-31T14:58:05+02:00https://rhiviera.com/publication/increasing-contribution-of-integrated-forms-to-total-hiv-dna-in-blood-during-hiv-disease-progression-from-primary-infection/2022-05-31T14:57:28+02:00https://rhiviera.com/publication/initiating-antiretroviral-treatment-early-in-infancy-has-long-term-benefits-on-the-hiv-reservoir-in-late-childhood-and-adolescence/2022-05-31T14:56:24+02:00https://rhiviera.com/publication/isotopic-radiolabeling-of-the-antiretroviral-drug-18fdolutegravir-for-pharmacokinetic-pet-imaging/2022-09-16T16:12:50+02:00https://rhiviera.com/publication/prolonged-antiretroviral-treatment-induces-adipose-tissue-remodelling-associated-with-mild-inflammation-in-siv-infected-macaques/2022-10-20T15:55:15+02:00https://rhiviera.com/publication/patterns-of-patient-and-healthcare-provider-viewpoints-regarding-participation-in-hiv-cure-related-clinical-trials-findings-from-a-multicentre-french-survey-using-q-methodology-anrs-apsec/2022-11-16T17:45:33+01:00https://rhiviera.com/publication/characterization-of-physicians-that-might-be-reluctant-to-propose-hiv-cure-related-clinical-trials-with-treatment-interruption-to-their-patients-the-anrs-apsec-study/2022-11-16T17:54:03+01:00https://rhiviera.com/publication/differences-in-hiv-cure-clinical-trial-preferences-of-french-people-living-with-hiv-and-physicians-in-the-anrs-apsec-study-a-discrete-choice-experiment/2022-11-16T17:52:05+01:00https://rhiviera.com/publication/will-cure-trials-introduce-an-uncomfortable-revolution-in-the-field-of-hiv-research/2022-11-16T17:49:20+01:00https://rhiviera.com/publication/in-depth-characterization-of-full-length-archived-viral-genomes-after-nine-years-of-posttreatment-hiv-control/2023-01-31T11:55:16+01:00https://rhiviera.com/publication/anti-v1-v3-glycan-broadly-hiv-1-neutralizing-antibodies-in-a-post-treatment-controller/2023-09-06T15:08:09+02:00https://rhiviera.com/publication/early-antiretroviral-therapy-favors-post-treatment-siv-control/2024-01-16T13:48:53+01:00https://rhiviera.com/publication/early-antiretroviral-therapy-favors-post-treatment-siv-control-copy/2025-11-05T15:03:00+01:00https://rhiviera.com/publication/early-antiretroviral-therapy-favors-post-treatment-siv-control-copy-copy/2025-11-05T15:22:46+01:00https://rhiviera.com/publication/early-antiretroviral-therapy-favors-post-treatment-siv-control-copy-copy-copy/2025-12-09T11:07:07+01:00https://rhiviera.com/publication/early-antiretroviral-therapy-favors-post-treatment-siv-control-copy-copy-copy-copy/2025-11-05T16:25:31+01:00https://rhiviera.com/publication/inhibition-of-alkbh5-demethylase-of-m6a-pathway-potentiates-hiv-1-reactivation-from-latency/2025-11-05T16:29:58+01:00https://rhiviera.com/publication/hiv-persistence-in-tissues-on-dolutegravir-based-therapy-is-not-associated-with-resistance-mutations-to-dolutegravir/2026-03-18T16:49:04+01:00https://rhiviera.com/publication/post-treatment-siv-control-is-associated-with-specific-features-of-viral-persistence-before-and-after-treatment-interruption/2026-03-18T17:01:06+01:00https://rhiviera.com/publication/maintenance-of-intestinal-cx3cr1-macrophage-homeostasis-defines-post-treatment-control-in-siv-infected-macaques/2026-03-18T16:48:05+01:00